Invesco Pharmaceuticals ETF
PJP
83 hedge funds and large institutions have $53.3M invested in Invesco Pharmaceuticals ETF in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 24 reducing their positions, and 11 closing their positions.
0.98% less ownership
Funds ownership: 20.61% → 19.63% (-0.98%)
5% less funds holding
Funds holding: 87 → 83 (-4)
19% less capital invested
Capital invested by funds: $65.9M → $53.3M (-$12.7M)
29% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 24
36% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$4.02M |
| 2 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$2.13M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$723K |
| 4 |
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
|
+$593K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$331K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PWW
Pettyjohn Wood & White
Lynchburg,
Virginia
|
-$7.43M |
| 2 |
Morgan Stanley
New York
|
-$3.6M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$2.52M |
| 4 |
HAS
HBW Advisory Services
Simi Valley,
California
|
-$1.08M |
| 5 |
QAM
Q3 Asset Management
Birmingham,
Michigan
|
-$1.05M |
PJP Hedge Fund Activity: Q3 2023 in Review
83 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q3 2023, worth a combined $53.3M — down 19% from $65.9M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of PJP and 7 opened new positions — a net loss of 4 holders — while 24 trimmed existing stakes and 17 added.
The largest buyer was UBS Group, adding an estimated $4.02M. The largest seller was Pettyjohn Wood & White, exiting entirely with an estimated $7.43M sold.
- 83 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q3 2023, down from 87 in Q2 2023.
- Funds reported $53.3M of Invesco Pharmaceuticals ETF stock for Q3 2023, down 19% quarter-over-quarter.
- 7 funds opened new Invesco Pharmaceuticals ETF positions in Q3 2023 and 11 closed out, a net change of -4 holders.
- The largest Invesco Pharmaceuticals ETF buyer in Q3 2023 was UBS Group, an estimated $4.02M added.
- The largest Invesco Pharmaceuticals ETF seller in Q3 2023 was Pettyjohn Wood & White, an estimated $7.43M sold.
Based on aggregated 13F filings for Q3 2023.